secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001367644-24-000134
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions sells RSDL decontamination kit to SERB for $75M
---------------------------------------------------------------------

- Cash purchase price of $75M at closing; additional $5M milestone payment for component sourcing.
- Sale includes Hattiesburg, MS manufacturing facility, IP, inventory, and marketing authorizations; employees to join SERB.
- Emergent's Winnipeg facility will manufacture bulk lotion for SERB under long-term supply agreement.
- SERB assumes existing RSDL supply contract with U.S. Department of Defense.
- Net proceeds expected to reduce debt by >$150M, targeting elimination of Junior Capital Raise requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000134/0001367644-24-000134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000134/ebs-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001367644-24-000134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer